Report      Database

    Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global

    Date: 28 Oct, 2013              Type: Life Science              Pages: 277

    Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global
    • Electronic Access - Single User License
      $1,590.00
    • CD-ROM Mail Delivery
      $1,690.00
    • Hard-copy Mail Delivery
      $1,840.00
    • Electronic Access - Multi User License
      $2,300.00

    Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018. 
     
    Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. 
     
    A. Global – Cancer Testing Market and New Cases (Chapter 2) 
    B. Global – Cancer Testing Market Share & Forecast (Chapter 3) 
    C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4) 
    D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5) 
    E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6) 
    F. Geographic Region – Number of New Cancer Cases (Chapter 7)
    G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8)
     
    Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4) 
     
    •  Prostate Specific Antigen (PSA) Test Market & Forecast
    •  Fecal Occult Blood Test Market & Forecast
    •  Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast
    •  Human Papilloma Virus (HPV) Test Market & Forecast
    •  Bladder Test Market & Forecast
    •  Serum Based Cancer Markers Market & Forecast
    •  Pharmacognostic Histology Market & Forecast
    •  Flow Cytometry  Market & Forecast
    •  Other Test Market & Forecast
     
    Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5) 
     
    •  Bladder Cancer Test Market & Forecast
    •  Breast Cancer Test Market & Forecast
    •  Cervical Cancer Test Market & Forecast 
    •  Colorectal (Colon) Cancer Test Market & Forecast
    •  Ovarian Cancer Test Market & Forecast
    •  Prostate Cancer Test Market & Forecast
    •  Liver Cancer Test Market & Forecast
    •  Flow Cytometry  Market & Forecast
    •  Other Organ Specific Cancer Test Market & Forecast
     
    Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6) 
     
    1.  Abbott 
    2.  Radient Pharmaceuticals  
    3.  BD Diagnostics 
    4.  Beckman Coulter, Inc. 
    5.  BioCurex 
    6.  bioMerieux  
    7.  Cepheid 
    8.  CytoCore Inc. 
    9.  DiagnoCure, Inc 
    10. Gen-Probe, Inc. 
    11. Genomic Health Inc
    12. QIAGEN Marseille (Earlier Ipsogen)
    13. Myriad Genetics, Inc
    14. Panacea Pharmaceuticals, Inc.
    15. Qiagen
    16. Siemens Heathcare Diagnostics 
    17. Roche
    18. Ventana Medical Systems
    19. Trovagene Inc
    20. Vermillion, Inc
     
    Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7) 
      
    1.  Africa
    2.  Americas
    3.  Asia
    4.  Europe
    5.  Oceania
      
    Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8)
     
    1.  Bladder Cancer 
    2.  Brain Cancer  
    3.  Breast Cancer 
    4.  Cervix Cancer  
    5.  Colorectal Cancer  
    6.  Corpus Cancer 
    7.  Hodgkin’s Lymphoma  
    8.  Kaposi Sarcoma 
    9.  Kidney Cancer 
    10. Larynx Cancer  
    11. Leukaemia 
    12. Liver Cancer  
    13. Lung Cancer 
    14. Melanoma 
    15. Myeloma
    16. Nasopharynx
    17. Non-Hodgkin Lymphoma
    18. Oesophagus
    19. Oral Cavity
    20. Other Pharynx
    21. Ovary Cancer
    22. Pancreas Cancer
    23. Prostate Cancer
    24. Stomach Cancer
    25. Testis Cancer
    26. Thyroid Cancer
    27. Other Sites
     
    Cancer Site - Clinical Trials (Chapter 8)
     
    1.  Bladder Cancer
    2.  Cervical Cancer
    3.  Colorectal Cancer
    4.  Liver Cancer 
    5.  Ovarian Cancer 
    6.  Prostate Cancer 
     
    Data Sources
     
    This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
     
    Primary sources include industry surveys and telephone interviews with industry experts. 
     
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. 

    1. Executive Summary
     
    2. Global – Cancer Testing Market and New Cases
    2.1 Global – Cancer Testing Market (2010 – 2018) 
    2.2 Global – Number of New Cancer Cases (2009 – 2020) 
     
    3. Global – Cancer Testing Market Share
    3.1 Global – Segment Wise Cancer Testing Market Share& Forecast (2011 – 2018) 
    3.2 Global – Organ Specific Cancer Testing Market Share & Forecast (2010 – 2018) 
     
    4. Global – Segment Wise Cancer Testing Market
    4.1 Prostate Specific Antigen (PSA) Test Market & Forecast (2010 – 2018) 
    4.2 Fecal Occult Blood Test Market & Forecast (2009 – 2018) 
    4.3 Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast (2010 – 2018) 
    4.4 Human PapillomaVirus (HPV) Test Market & Forecast (2010 – 2018) 
    4.5 Bladder Test Market & Forecast (2010 – 2018) 
    4.6 Serum Based Cancer Markers Market & Forecast (2008 – 2018) 
    4.7 Pharmacognostic Histology Market & Forecast (2011 – 2018) 
    4.8 Flow Cytometry  Market & Forecast (2011 – 2018) 
    4.9 Other Test Market& Forecast (2011 – 2018) 
     
    5. Global – Organ Specific Cancer Testing Market
    5.1 Bladder Cancer Test Market& Forecast (2010 – 2018) 
    5.2 Breast Cancer Test Market & Forecast (2010 – 2018) 
    5.3 Cervical Cancer Test Market & Forecast (2010 – 2018) 
    5.4 Colorectal (Colon) Cancer Test Market & Forecast (2010 – 2018) 
    5.5 Ovarian Cancer Test Market & Forecast (2010 – 2018) 
    5.6 Prostate Cancer Test Market & Forecast (2010 – 2018) 
    5.7 Liver Cancer Test Market & Forecast (2010 – 2018) 
    5.8 Other Organ Specific Cancer Test Market & Forecast (2010 – 2018) 
     
    6. Cancer Diagnostics– Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis) 
    6.1 Abbott

    6.1.1 Abbott – Cancer Test Platforms
    6.1.2 Abbott's Cancer Pipeline Analysis
     
    6.2 Radient Pharmaceuticals
    6.2.1 Radient Pharmaceuticals – Cancer Test Platforms
     
    6.3 BD Diagnostics
    6.3.1 BD Diagnostics – Cancer Test Platform
    6.3.2 BD Diagnostics Pipeline Analysis
     
    6.4 Beckman Coulter, Inc. 
    6.4.1 Beckman Coulter, Inc. – Cancer Test platform
     
    6.5 BioCurex
    6.5.1 BioCurex – Cancer Test Platform
    6.5.2 BioCurex – Pipeline Analysis
     
    6.6 bioMerieux
    6.6.1 bioMerieux – Cancer Test Platform
    6.6.2 bioMérieux - Pipeline Analysis
     
    6.7 Cepheid
    6.7.1 Cepheid – Cancer Test Platform
    6.7.2 Cepheid – Pipeline Analysis
     
    6.8 CytoCore Inc. 
    6.8.1 CytoCore Inc. – Cancer Test Platform
    6.8.2 CytoCore Inc. –    Pipeline Analysis
     
    6.9 DiagnoCure, Inc. 
    6.9.1 DiagnoCure, Inc. – Cancer Test Platform
    6.9.2 DiagnoCure Inc. – Pipeline Analysis
     
    6.10 Gen-Probe, Inc. 
    6.10.1 Gen-Probe, Inc. – Cancer Test Platform
     
    6.11 Genomic Health Inc. 
    6.11.1 Genomic Health Inc. – Cancer Test Platform
    6.11.2 GenomicHealth, Inc. – Pipeline Analysis
     
    6.12 QIAGEN Marseille (Earlier Ipsogen) 
    6.12.1 QIAGEN Marseille – Cancer Test Platform
     
    6.13 Myriad Genetics, Inc
    6.13.1 Myriad Genetics, Inc – Cancer Test Platform
    6.13.2 Myriad Genetics, Inc – Pipeline Analysis
     
    6.14 Panacea Pharmaceuticals, Inc. 
    6.14.1 Panacea Pharmaceuticals, Inc. – Cancer Test Platform
     
    6.15 Qiagen
    6.15.1 Qiagen – Cancer Test Platform
    6.15.2 Qiagen – Pipeline Analysis
     
    6.16 Siemens Heathcare Diagnostics
    6.16.1 Siemens Heathcare Diagnostics – Cancer Test Platform
     
    6.17 Roche
    6.17.1 Roche – Cancer Test Platform
    6.17.2 Roche – Pipeline Analysis
     
    6.18 Ventana Medical Systems, Inc. 
    6.18.1 Ventana Medical Systems, Inc. – Cancer Test Platform
     
    6.19 TrovageneInc. 
    6.19.1 Trovagene, Inc. – Cancer Test Platform
    6.19.2 TrovageneInc. – Pipeline Analysis
     
    6.20 Vermillion, Inc
    6.20.1 Vermillion, Inc – Cancer Test Platform
     
    7. Geographic Region – Number of New Cancer Cases
    7.1 Africa – Number of New Cancer Cases & Forecast (2009 – 2020) 
    7.2 Americas – Number of New Cancer Cases & Forecast (2009 – 2020) 
    7.3 Asia – Number of New Cancer Cases & Forecast (2009 – 2020) 
    7.4 Europe – Number of New Cancer Cases & Forecast (2009 – 2020) 
    7.5 Oceania – Number of New Cancer Cases & Forecast (2009 – 2020) 
     
    8. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials
    8.1 Bladder Cancer Number of New Cases & Clinical Trials

    8.1.1 Bladder Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
    8.1.2 Bladder Cancer – Tests Being Studied in Clinical Trials
     
    8.2 Brain Cancer Number of New Cases
    8.2.1 Brain Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.3 Breast Cancer Number of New Cases
    8.3.1 Breast Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.4 Cervix Cancer Number of New Cases & Clinical Trials
    8.4.1 Cervix Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 
    8.4.2 Cervical Cancer – Test Being Studied in Clinical Trials
     
    8.5 Colorectal Cancer Number of New Cases & Clinical Trials
    8.5.1 Colorectal Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
    8.5.2 Colorectal Cancer – Test Being Studied in Clinical Trials
     
    8.6 Corpus Cancer Number of New Cases
    8.6.1 Corpus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.7 Hodgkin’s Lymphoma Number of New Cases
    8.7.1 Hodgkin’s Lymphoma Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 
     
    8.8 Kaposi Sarcoma Number of New Cases
    8.8.1 Kaposi Sarcoma Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.9 Kidney Cancer Number of New Cases
    8.9.1 Kidney Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.10 Larynx Cancer Number of New Cases
    8.10.1 Larynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.11 Leukaemia Number of New Cases
    8.11.1 Leukaemia Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.12 Liver Cancer Number of New Cases & Clinical Trials
    8.12.1 Liver Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
    8.12.2 Liver Cancer – Test Being Studied in Clinical Trials
     
    8.13 Lung Cancer Number of New Cases
    8.13.1 Lung Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.14 Melanoma Number of New Cases
    8.14.1 Melanoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.15 Myeloma Number of New Cases
    8.15.1 Myeloma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.16 Nasopharynx Number of New Cases
    8.16.1 Nasopharynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.17 Non-Hodgkin Lymphoma Number of New Cases
    8.17.1 Non-Hodgkin Lymphoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.18 Oesophagus Number of New Cases
    8.18.1 Oesophagus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.19 Oral Cavity Number of New Cases
    8.19.1 Oral Cavity Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.20 Other Pharynx Number of New Cases
    8.20.1 Other Pharynx Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.21 Ovary Cancer Number of New Cases & Clinical Trials
    8.21.1 Ovary Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
    8.21.2 Ovarian Cancer – Tests Being Studied In Clinical Trials
     
    8.22 Pancreas Cancer Number of New Cases
    8.22.1 Pancreas Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.23 Prostate Cancer Number of New Cases & Clinical Trials
    8.23.1 Prostate Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 
    8.23.2 Prostate Cancer – Test Being Studied in Clinical Trials
     
    8.24 Stomach Cancer Number of New Cases
    8.24.1 Stomach Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.25 Testis Cancer Number of New Cases
    8.25.1 Testis Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
     
    8.26 Thyroid Cancer Number of New Cases
    8.26.1 Thyroid Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
    8.27 Other Sites – Number of New Cases

    Figure 2 1: Global – Cancer Test Market (Million US$), 2010 – 2012
    Figure 2 2: Global – Forecast for Cancer Test Market (Million US$), 2013 – 2018
    Figure 2 3: Global – Number of New Cancer Cases (Number), 2009 – 2012
    Figure 2 4: Global – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
     
    Figure 3 1: Global – Segment Wise Cancer Test Market Share (Percent), 2011 – 2012
    Figure 3 2: Global – Forecast for Segment Wise Cancer Test Market Share (Percent), 2013 – 2018
    Figure 3 3: Global – Organ Specific Cancer Testing Market Share (Percent), 2010 – 2012
    Figure 3 4: Global – Forecast for Organ Specific Cancer Testing Market Share (Percent), 2013 – 2018
     
    Figure 4 1: Global – PSA Test Market (Million US$), 2010 –2012
    Figure 4 2: Global – Forecast for PSA Test Market (Million US$), 2013 –2018
    Figure 4 3: Global – Fecal Occult Blood Test Market (Million US$), 2009 –2012
    Figure 4 4: Global – Forecast for Occult Blood Test Market (Million US$), 2013 –2018
    Figure 4 5: Global – FISH Test Market (Million US$), 2010 – 2012
    Figure 4 6: Global – Forecast for FISH Test Market (Million US$), 2013 – 2018
    Figure 4 7: Global – HPV Test Market (Million US$), 2010 – 2012
    Figure 4 8: Global – Forecast for HPV Test Market (Million US$), 2013 – 2018
    Figure 4 9: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012
    Figure 4 10: Global – Forecast for Bladder Test Market (Million US$), 2013 – 2018
    Figure 4 11: Global – Serum Based Cancer Markers Market (Million US$), 2008 – 2012
    Figure 4 12: Global – Forecast for Serum Based Cancer Markers Market (Million US$), 2013 – 2018
    Figure 4 13: Global – Pharmacognostic Histology Market (Million US$), 2011 – 2012
    Figure 4 14: Global – Forecast for Pharmacognostic Histology Market (Million US$), 2013 – 2018
    Figure 4 15: Global – Flow Cytometry Market (Million US$), 2011 – 2012
    Figure 4 16: Global – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018
    Figure 4 17: Global – Other Test Market (Million US$), 2011 – 2012
    Figure 4 18: Global – Forecast for Other Test Market (Million US$), 2013 – 2018
     
    Figure 5 1: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 2: Global – Forecast for Bladder Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 3: Global – Breast Cancer Test Market (Million US$), 2010 – 2013
    Figure 5 4: Global – Forecast for Breast Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 5: Global – Cervical Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 6: Global – Forecast for Cervical Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 7: Global – Colorectal (Colon) Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 8: Global – Forecast for Colorectal (Colon) Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 9: Global – Ovarian Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 10: Global – Forecast for Ovarian Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 11: Global – Prostate Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 12: Global – Forecast for Prostate Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 13: Global – Liver Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 14: Global – Forecast for Liver Cancer Test Market (Million US$), 2013 – 2018
    Figure 5 15: Global – Other Organ Cancer Test Market (Million US$), 2010 – 2012
    Figure 5 16: Global – Forecast for Other Organ Cancer Test Market (Million US$), 2013 – 2018
     
    Figure 7 1: Africa –Number of New Cancer Cases (Number), 2009 – 2012
    Figure 7 2: Africa – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
    Figure 7 3: Americas –Number of New Cancer Cases (Number), 2009 – 2012
    Figure 7 4: Americas – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
    Figure 7 5: Asia –Number of New Cancer Cases (Number), 2009 – 2012
    Figure 7 6: Asia – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
    Figure 7 7: Europe – Number of New Cancer Cases (Number), 2009 – 2012
    Figure 7 8: Europe – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
    Figure 7 9: Oceania –Number of New Cancer Cases (Number), 2009 – 2012
    Figure 7 10: Oceania – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
     
    List of Tables:
     
    Table 6 1: Effectiveness of Onko-Sure Within Different Cancer Types
    Table 6 2: Beckman Coulter – Flow Cytometry Technology portfolio and Various Bundling Options
    Table 6 3: Beckman Coulter – Hematology Test Product portfolio
    Table 6 4: bioMérieux – Tumor Markers offerings for Various Cancer
     
    Table 8 1: Bladder– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 2: Bladder– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 3: Brain– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 4: Brain– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 5: Breast – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 6: Breast– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 7: Cervix– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 8: Cervix– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 9: Colorectal– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 10: Colorectal– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 11: Corpus– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 12: Corpus– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 13: Hodgkin’s Lymphoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 14: Hodgkin’s Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 15: Kaposi Sarcoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 16: Kaposi Sarcoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 17: Kidney– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 18: Kidney– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 19: Larynx– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 20: Larynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 21: Leukaemia – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 22: Leukaemia– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 23: Liver – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 24: Liver– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 25: Lung – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 26: Lung– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 27: Melanoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 28: Melanoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 29: Myeloma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 30: Myeloma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 31: Nasopharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 32: Nasopharynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 33: Non-Hodgkin Lymphoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 34: Non-Hodgkin Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 35: Oesophagus – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 36: Oesophagus – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 37: Oral Cavity– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 38: Oral Cavity – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 39: Other Pharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 40: Other Pharynx – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 41: Ovary – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 42: Ovary – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 43: Pancreas – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 44: Pancreas – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 45: Prostate – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 46: Prostate – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 47: Stomach – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 48: Stomach – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 49: Testis – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 50: Testis – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 51: Thyroid – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 52: Thyroid – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
    Table 8 53: Other Sites – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
    Table 8 54: Other Sites – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020 


    Related Products